11. Parkinsonism and spastic paraplegia type 7: Expanding the spectrum of mitochondrial Parkinsonism. Issue 10 (21st August 2019) Authors: De la Casa‐Fages, Beatriz; Fernández‐Eulate, Gorka; Gamez, Josep; Barahona‐Hernando, Raúl; Morís, Germán; García‐Barcina, María; Infante, Jon; Zulaica, Miren; Fernández‐Pelayo, Uxoa; Muñoz‐Oreja, Mikel; Urtasun, Miguel; Olaskoaga, Ander; Zelaya, Victoria; Jericó, Ivonne; Saez‐Villaverde, Raquel; ... Journal: Movement disorders Issue: Volume 34:Issue 10(2019) Page Start: 1547 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
12. Randomized phase 2 study of ACE‐083, a muscle‐promoting agent, in facioscapulohumeral muscular dystrophy. Issue 1 (9th May 2022) Authors: Statland, Jeffrey M.; Campbell, Craig; Desai, Urvi; Karam, Chafic; Díaz‐Manera, Jordi; Guptill, Jeffrey T.; Korngut, Lawrence; Genge, Angela; Tawil, Rabi N.; Elman, Lauren; Joyce, Nanette C.; Wagner, Kathryn R.; Manousakis, Georgios; Amato, Anthony A.; Butterfield, Russell J.; Shieh, Perry B.; Wi... Journal: Muscle & nerve Issue: Volume 66:Issue 1(2022) Page Start: 50 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
13. Reply to: "Mitochondrial Parkinsonism due to SPG7/Paraplegin variants with secondary mtDNA depletion". Issue 12 (17th December 2019) Authors: De la Casa‐Fages, Beatriz; Fernández‐Eulate, Gorka; Gamez, Josep; Barahona‐Hernando, Raúl; Morís, Germán; García‐Barcina, María; Infante, Jon; Zulaica, Miren; Fernández‐Pelayo, Uxoa; Muñoz‐Oreja, Mikel; Urtasun, Miguel; Olaskoaga, Ander; Zelaya, Victoria; Jericó, Ivonne; Saez‐Villaverde, Raquel; ... Journal: Movement disorders Issue: Volume 34:Issue 12(2019) Page Start: 1932 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
14. Safety and efficacy of leriglitazone for preventing disease progression in men with adrenomyeloneuropathy (ADVANCE): a randomised, double-blind, multi-centre, placebo-controlled phase 2–3 trial. Issue 2 (February 2023) Authors: Köhler, Wolfgang; Engelen, Marc; Eichler, Florian; Lachmann, Robin; Fatemi, Ali; Sampson, Jacinda; Salsano, Ettore; Gamez, Josep; Molnar, Maria Judit; Pascual, Sílvia; Rovira, Maria; Vilà, Anna; Pina, Guillem; Martín-Ugarte, Itziar; Mantilla, Adriana; Pizcueta, Pilar; Rodríguez-Pascau, Laura; Tra... Journal: Lancet neurology Issue: Volume 22:Issue 2(2023) Page Start: 127 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
15. Safety of mRNA COVID‐19 vaccines in patients with well‐controlled myasthenia gravis. Issue 5 (27th August 2022) Authors: Gamez, Josep; Gamez, Alejandro; Carmona, Francesc Journal: Muscle & nerve Issue: Volume 66:Issue 5(2022) Page Start: 612 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
16. Serum Autoantibody Lowering by the Anti-FcRn Monoclonal Antibody, Nipocalimab, Correlates With Clinical Improvement in Generalized Myasthenia Gravis Patients. (5th December 2022) Authors: Ramchandren, Sindhu; Guptill, Jeff; Antozzi, Carlo; Bril, Vera; Gamez, Josep; Meuth, Sven; Nowak, Richard; Quan, Dianna; Sevilla Mantecon, Maria Teresa; Ling, Leona; Zhu, Yaowei; Karcher, Keith; Sun, Hong Journal: Neurology Issue: Volume 99:Number 23(2022)Supplement 2 Page Start: S35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
17. Serum Autoantibody Lowering by the Anti-FcRn Monoclonal Antibody, Nipocalimab, Correlates With Clinical Improvement in Generalized Myasthenia Gravis Patients. (5th December 2022) Authors: Ramchandren, Sindhu; Guptill, Jeff; Antozzi, Carlo; Bril, Vera; Gamez, Josep; Meuth, Sven; Nowak, Richard; Quan, Dianna; Sevilla Mantecon, Maria Teresa; Ling, Leona; Zhu, Yaowei; Karcher, Keith; Sun, Hong Journal: Neurology Issue: Volume 99:Number 23(2022)Supplement 2 Page Start: S35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
18. Serum Autoantibody Lowering by the Anti-FcRn Monoclonal Antibody, Nipocalimab, Correlates With Clinical Improvement in Generalized Myasthenia Gravis Patients. (5th December 2022) Authors: Ramchandren, Sindhu; Guptill, Jeff; Antozzi, Carlo; Bril, Vera; Gamez, Josep; Meuth, Sven; Nowak, Richard; Quan, Dianna; Sevilla Mantecon, Maria Teresa; Ling, Leona; Zhu, Yaowei; Karcher, Keith; Sun, Hong Journal: Neurology Issue: Volume 99:Number 23(2022)Supplement 2 Page Start: S35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
19. Transthyretin stabilization activity of the catechol-O-methyltransferase inhibitor tolcapone (SOM0226) in hereditary ATTR amyloidosis patients and asymptomatic carriers: proof-of-concept study#. (3rd April 2019) Authors: Gamez, Josep; Salvadó, María; Reig, Núria; Suñé, Pilar; Casasnovas, Carles; Rojas-Garcia, Ricard; Insa, Raúl Journal: Amyloid Issue: Volume 26:Number 2(2019) Page Start: 74 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
20. Transthyretin stabilization activity of the catechol-O-methyltransferase inhibitor tolcapone (SOM0226) in hereditary ATTR amyloidosis patients and asymptomatic carriers: proof-of-concept study. (3rd April 2019) Authors: Gamez, Josep; Salvadó, María; Reig, Núria; Suñé, Pilar; Casasnovas, Carles; Rojas-Garcia, Ricard; Insa, Raúl Journal: Amyloid Issue: Volume 26:Number 2(2019) Page Start: 74 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗